# Tenofovir in Pregnancy to Prevent Mother to Child Transmission of Hepatitis B.

> **NCT04114890** · PHASE2 · COMPLETED · sponsor: **University of Oxford** · enrollment: 27 (actual)

## Conditions studied

- Hepatitis B
- Tenofovir
- Pregnancy

## Interventions

- **DRUG:** Tenofovir Disoproxil Fumarate

## Key facts

- **NCT ID:** NCT04114890
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-08
- **Primary completion:** 2023-09-29
- **Final completion:** 2023-09-29
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2024-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04114890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04114890, "Tenofovir in Pregnancy to Prevent Mother to Child Transmission of Hepatitis B.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04114890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*